Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026)
Lantheus Holdings (LNTH) reported Retained Earnings of -$1.9 million for Q1 2026, down 100.36% year-over-year from $518.9 million in Q1 2025, and down 100.27% quarter-over-quarter from $679.5 million in Q4 2025.
Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Retained Earnings data on file, last reported at -$1.9 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.9 million, down 100.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 100.36% YoY), and the FY2025 annual result was $679.5 million, up 42174.55% from the prior year.
- Retained Earnings fell to -$1.9 million in Q1 2026 per LNTH's latest filing, from $679.5 million in the prior quarter.
- Over five years, Retained Earnings peaked at $679.5 million in Q4 2025 and troughed at -$196.0 million in Q1 2023.
- A 5-year average of $65.2 million and a median of -$1.2 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings slumped 10354.58% in 2023, then jumped 44148.39% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$1.3 million in 2022, then rose by 17.63% to -$1.0 million in 2023, then slumped by 55.74% to -$1.6 million in 2024, then surged by 42174.55% to $679.5 million in 2025, then slumped by 100.27% to -$1.9 million in 2026.
- Business Quant data shows LNTH's Retained Earnings at -$1.9 million in Q1 2026, $679.5 million in Q4 2025, and -$1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.87 Mn |
| Dec 31, 2025 | 679.50 Mn |
| Sep 30, 2025 | -1.67 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | 518.89 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | 326.64 Mn |
| Mar 31, 2024 | -1.18 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.04 Mn |
| Jun 30, 2023 | -952,000.00 |
| Mar 31, 2023 | -195.97 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | -73.97 Mn |
| Jun 30, 2022 | -135.21 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | -221.23 Mn |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -167.60 Mn |